Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy-Reference-Cited by-同舟云学术

Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy

Published:2016-03-07 Issue:5 Volume:31 Page:742-747
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Stamelou Maria¹²³,Schöpe Jakob⁴,Wagenpfeil Stefan⁴,Del Ser Teodoro⁵⁶,Bang Jee⁷,Lobach Iryna Y.⁷,Luong Phi⁷,Respondek Gesine⁷,Oertel Wolfgang H.¹,Boxer AdamL.⁷,Höglinger Günter U.¹⁸⁹,

Affiliation:

1. Department of Neurology; Philipps University; Marburg Germany

2. Second Department of Neurology, Attikon University Hospital; University of Athens; Athens Greece

3. Movement Disorders Department; Hygeia Hospital; Athens Greece

4. Institute for Medical Biometry, Epidemiology and Medical Informatics, Saarland University; Campus Homburg Homburg Germany

5. Medical Department; Noscira SA, Madrid; Spain

6. Alzheimer Project Research Unit; Fundación CIEN; Madrid Spain

7. Memory and Aging Center; Department of Neurology; University of California; San Francisco California USA

8. Department of Neurology; Technische Universität München; Munich Germany

9. German Center for Neurodegenerative Diseases (DZNE); Munich Germany

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference29 articles.

1. Disease-modifying treatments for progressive supranuclear palsy;Stamelou;Mov Disord Clin Pract,2015

2. A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy;Tolosa;Mov Disord,2014

3. Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial;Boxer;Lancet Neurol,2014

4. Clinical trials: past, current, and future for atypical parkinsonian syndromes;Tsai;Semin Neurol,2014

5. Progressive supranuclear palsy: a survey of the disease course;Santacruz;Neurology,1998

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative Comparisons of Progressive Supranuclear Palsy Rating Scale Versions Using Item Response Theory;Movement Disorders;2024-08-29

2. Magnetic Resonance Imaging Measures to Track Atrophy Progression in Progressive Supranuclear Palsy in Clinical Trials;Movement Disorders;2024-06-02

3. Balloon Eustachian Tuboplasty—A Feasible Double‐Blinded Sham Surgery Randomized Clinical Trial Protocol to Study Efficacy;The Laryngoscope;2023-09-30

4. Efficacy of faecal microbiota transplantation in patients with progressive supranuclear palsy-Richardson's syndrome: a phase 2, single centre, randomised clinical trial;eClinicalMedicine;2023-04

5. Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trials;Brain;2023-03-28